Results 261 to 270 of about 128,988 (349)

Development of pH-Sensitive Multiparticulates for Orally Disintegrating Tablets of Proton Pump Inhibitors: Physicochemical Characterization and Drug Release Studies. [PDF]

Pharmaceutics
Singh M, Ullapu PR, Mariadoss AVA, Kumar S, Kang SG.   +4 more
europepmc   +1 more source

The association between proton pump inhibitors and the risk of gastrointestinal bleeding in oral anticoagulants users. [PDF]

NPJ Cardiovasc Health
Wang Z, Yu Q, Warren-Gash C, Bhaskaran K, Leyrat C, Cheung KS, Chui CSL, Chan EW, Wong ICK, Banerjee A, Smeeth L, Douglas IJ, Wong AYS.   +12 more
europepmc   +1 more source

Influence of proton pump inhibitors on the incidence and clinical course of oesophageal fistula following catheter ablation for atrial fibrillation: a subanalysis of the POTTER-AF study. [PDF]

Europace
Beiert T, Knappe V, Zietzer A, Schmidt V, Pürerfellner H, Sommer P, Sohns C, Veltmann C, Steven D, Chun KJ, Maury P, Gandjbakhch E, Laredo M, Willems S, Borlich M, Füting A, Spittler R, Richter S, Schade A, Kuniss M, Wunderlich C, Shin DI, Meininghaus DG, Bonsels M, Reek D, Wiegand U, Bauer A, Metzner A, Eckardt L, Krahnefeld O, Sticherling C, Kühne M, Nguyen DQ, Roten L, Linz D, van der Voort P, Mulder BA, Vijgen J, Almorad A, Guenancia C, Fauchier L, Boveda S, De Greef Y, Da Costa A, Jais P, Milhem A, Jesel L, Garcia R, Poty H, Khoueiry Z, Seitz J, Laborderie J, Mechulan A, Brigadeau F, Zhao A, Saludas Y, Piot O, Ahluwalia N, Martin CA, Chen J, Antolic B, Leventopoulos G, Özcan EE, Yorgun H, Cay S, Yalin K, Botros MS, Jędrzejczyk-Patej E, Inaba O, Okumura K, Ejima K, Khakpour H, Catanzaro JN, Reddy V, Natale A, Blessberger H, Yang B, Vogler J, Kuck KH, Merino JL, Keelani A, Heeger CH, Popescu SS, Tilz RR.   +83 more
europepmc   +1 more source

B cells and systemic sclerosis interstitial lung disease

Arthritis &Rheumatology, Accepted Article.
Interstitial lung disease is an important complication of systemic sclerosis (SSc‐ILD) with high mortality and morbidity. Recent clinical studies in SSc‐ILD have led to FDA‐approved therapies in SSc‐ILD. Importantly, evidence from these studies has been extrapolated to guide management of interstitial lung diseases of other systemic autoimmune ...
Nina Goldman, Voon Ong, Christopher Denton   +2 more
wiley   +1 more source

Use of Proton Pump Inhibitors Among Patients With Alcohol-Related Cirrhosis-A Danish Nationwide Cohort Study. [PDF]

Liver Int
Ramsing MS, Jensen MD, Jepsen P.
europepmc   +1 more source

Synthesis, Photophysical Properties, and Practical Hg(II)‐Sensing Applications of a Rigidified Phenolo‐Merocyanine Dye

Chemistry – An Asian Journal, EarlyView.
Rigidity for performance!!! A novel conformationally restrained phenolic merocyanine was synthesized in order to obtain a fluorogenic dye with outstanding spectral properties at physiological pH (fluorescence brightness > 71,000 M−1 cm−1). The utility of its optically tunable hydroxyl group was illustrated with a thiophosphinate‐based chemodosimeter ...
Kévin Renault, Zuzana Pohancenikova, Maël Croizier, Vincent Gaumerd, Manhattan Lebrun, Michel Chalot, Anthony Romieu   +6 more
wiley   +1 more source

Does the use of proton pump inhibitors lead to an increased risk of dental implant failure? A systematic review and meta-analysis. [PDF]

Med Oral Patol Oral Cir Bucal
Tang M, Xie Z.
europepmc   +1 more source

A New Era for Using Natural Pigments: The Case of the C50 Carotenoid Called Bacterioruberin

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Haloarchaea are extremophilic microorganisms belonging to the Archaea domain that require high salt concentrations to live, thus inhabiting ecosystems like salty ponds, salty marshes, or extremely salty lagoons. They are more abundant and widely distributed worldwide than initially expected.
Micaela Giani, Elena Valdés, José María Miralles‐Robledillo, Guillermo Martínez, Carmen Pire, Rosa María Martínez‐Espinosa   +5 more
wiley   +1 more source

Management of uninvestigated dyspepsia: A randomized, double-blind, placebo-controlled trial of proton pump inhibitor therapy

, 2001
Linda Rabeneck, Julianne Souchek, Kimberly Wristers, Terri Menke, Naomi R. Wray, Eunice Ambriz, Iris W. Huang   +6 more
openalex   +1 more source